AK

Anil Kumar

Active Director Director DIN 08944404
DIN 08944404 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Anil Kumar

Data last updated:

Anil Kumar is a Director at Marvellon Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Marvellon Pharmaceuticals Private Limited reported revenue of ₹4.96 Cr (FY 2025).

DIN 08944404
Primary Designation Director
Industry Pharma
First Appointment 27 Oct 2020
Oldest Company Age 7 yrs
Largest company Marvellon Pharmaceuticals Private Limited · ₹4.96 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Oct 20202019₹4.96 Cr (FY 2025)Active

Board colleagues of Anil Kumar

NameDINCompanyDesignation
Amit Kumar08942288Marvellon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Marvellon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar

Anil Kumar currently holds 1 directorship: Marvellon Pharmaceuticals Private Limited (Director, since 27 Oct 2020, revenue ₹4.96 Cr (FY 2025)).

Anil Kumar was first appointed on 27 Oct 2020 as Director at Marvellon Pharmaceuticals Private Limited.

The current boards of Anil Kumar's companies include Amit Kumar (Marvellon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available